Patients & Volunteers Information for those interested or currently participating in a clinical trial
	Research Sponsors Why you should choose Aurora for your clinical trials
	Investigators & Coordinators Learn more about our services
	Research Matters Quarterly newsletter about research at Aurora
	Links Learn more about clinical research
	Contact us Contact the Clinical Research department
	Return home Return to the Clinical Research home page

Select from the search options to widen or narrow the search results.

Cardiovascualar Outcomes in Renal Atherosclerotic Lesions is a study evaluating the effectiveness of renal stenting and expert medical management against expert medical management alone for people who suffer from HTN and renal artery stenosis.

To Qualify you must:

• Be at least 18 years of age
• Have either a documented history of hypertensiion on 2 or more anti-hypertensive medications or
• have renal dysfunction defined as stage 3 or greater CKD based on NKF classifications.
• have renal artery stenosis (documented by multilple forms of imaging)
• You cannot be pregnant
• allergic to stainless steel
• willing to comply with all study procedures.

Subjects will recieve study drug of Atacand or Atacand/HCT and Caduet for the duration of the study, which could last up to 5 years.

Interested participants should contact:

Lynda Yanny, RN Research Coordninator at 414.649.6685

Investigators:  Dr. Robert Beres, Dr. Daniel Bloomgarden, Dr. Gregory Warren and Dr. Ahmed Malik.

Clinical trial location(s)

Private Physician's Office

,

[ previous page ]

Copyright Aurora Health Care, a not-for-profit health care provider serving Wisconsin.
3000 W. Montana St., Milwaukee, WI 53215, (414) 647-3000
Disclaimer | Privacy notice | Contact us
.